New FDA approved “brain test” for ADHD—is bogus

Given the enormous potential for great harm, one has to wonder how the Food and Drug Administration, FDA, gets away with giving its stamp of approval on a new “brain wave test,” that allegedly will “help confirm an ADHD diagnosis,” when there is no scientific or medical proof that any physical abnormality exists. What part of approving a “brain waive test” for a psychiatric diagnosis that doesn’t exist is “assuring the safety and effectiveness?” More to the point, since there is no proof that the alleged psychiatric diagnosis exists, how can the FDA possibly claim that any test, least of all one that consists of interpreting squiggly lines on a piece of paper, is safe or effective?

Another Assault on America’s Children—Electroshocking kids promoted as “safe & effective”

Dr. Peter Breggin, a psychiatrist, author and medical expert describes ECT this way: “Shock treatment is simply closed-head injury caused by an overwhelming current of electricity sufficient to cause a grand mal seizure. When the patient becomes apathetic, the doctor writes in the hospital chart, ‘No longer complaining.’ When the patient displays the euphoria commonly associated with brain damage, the doctor writes ‘mood improved.’ Meanwhile, the individual’s brain and mind are so drastically injured that he or she is rendered unable to protest.”

ADHD Drugs: New Study Reveals the Fraud of “Kiddie Cocaine”

For decades, ADHD drugs, like Ritalin and Adderall, have been called “kiddie cocaine” because the drugs produce similar effects as cocaine. Now, finally, research proves that just like cocaine doesn’t make a genius, the prescription psychiatric drugs prescribed to “treat” ADHD don’t make children smart.

Could Malaria Drug Used by the Military be Responsible for Afghan Massacre?

The U.S. military is ignoring documented evidence that links a violence-inducing prescription drug with the worst American war crime in decades -- the massacre last year of 16 Afghan civilians by Army Sgt. Robert Bales.

Labeling Kids ADHD—Are We Dumbing Down our Innovators of Tomorrow with Drugs?

Nearly one in five American high school students has been diagnosed with attention-deficit hyperactivity disorder, ADHD, and most are subsequently put on medication to treat this "disorder". What are the long-term effects of these drugs, not only on their health, but on the world's future? It is quite likely that in our effort to "normalize" our children, we are in fact destroying the next generation of American leaders and innovators.

The Psychiatrist Whistleblower Big Pharma Can’t Shut Up

For the last 33 years, David Healy, an Irish psychiatrist and professor at Cardiff University School of Medicine in Wales, has written heavily researched university press books and academic journal articles on various aspects of psychopharmaceuticals. His output includes 20 books, 150 peer-reviewed papers and 200 other published works. He is not only well-pedigreed, with degrees and fellowships from Dublin, Galway and Cambridge medical schools, he is a widely recognized expert in both the history and the science of neurochemistry and psychopharmacology. Yet Healy says his output and reputation have had little to no effect—both on the pharmaceutical industry he argues buries relevant information about prescription drug harms, and on the psychiatric and medical professions he claims are being “eclipsed” by drug companies. Americans consume 80 percent of opiate painkillers produced in the world. A January 2011 report from Stanford University Medical School warned that antispychotics are now regularly being prescribed to treat conditions for which they have not been approved, including anxiety, attention-deficit disorder, sleep difficulties, behavioral problems in toddlers and dementia. According to a Feb. 7, 2013 report from Drugs.com, the No. 1 best-selling U.S. drug (in dollar volume) is an atypical antipsychotic for schizophrenia treatment called Abilify. Sales for the last quarter of 2012 soared to $1.5 billion, because Abilify is widely prescribed off-label—i.e., not for schizophrenia in adults, but, for example, for irritability in children. Although Bristol-Myers Squibb, the maker of Abilify, was fined $515 million in September 2007 for recommending off-label uses of Abilify, doctors are still doling out the drug. Why?

Obama Endorses Sweeping Mental Health Programs Just As Psychiatry’s Diagnostic Manual Comes Under Fire

The White House’s sweeping mental health initiatives—which rely on psychiatry’s diagnostic procedures—do not take into account the major controversy currently raging over the lack of science behind psychiatry’s methods of diagnosing mental disorders. Should the conversation suggested by the President be restricted to supporting mental health informational initiatives based on a flawed, unsafe diagnosing manual, things may progress as Dr. Allen Frances predicts: "soon most of us will have a fake mental disorder (or a few) and we will live in a Brave New World where nearly everyone uses medicine.”

How a Scientific Field Can Collapse: The Case of Psychiatry

Are psychiatrists just giving excuses for irresponsible behavior? Psychiatry lacks scientific footing, and instead evolves according to cultural norms.

How a Homeschool Mom Fought Back Against CPS and Won Her Daughter Back

Maryanne Godboldo and Allison Folmar are extraordinary women. Their names may not elicit immediate recognition by the masses but it is because of their belief in the right of parents—not the state—to decide whether to medicate a child, that their struggle will protect thousands of children who otherwise would have become victims of deeply flawed State Child Protective Services policies.

700 Percent Increase in Number of Psych Drugs Prescribed to Active Soldiers Leads to More Deaths by Suicide than Deaths by Combat

Last year, more active-duty soldiers committed suicide than died in battle. According to data not reported on until now, the military evidently responded to stress that afflicts soldiers in Iraq and Afghanistan primarily by drugging soldiers on the front lines.